Going to Singapore to treat heart failure with stem cells

In the press conference "Introducing new methods of treating cardiovascular disease" in Ho Chi Minh City on May 5, BS. Eugene Sim, BS Cardiology Parkway Medical Group - Singapore said that for patients with end-stage heart failure, with no cure, Singapore is developing treatment by transplanting stem cells and using mechanical heart support devices.

Parkway - Singapore

All stem cells used for transplantation for heart failure patients are stem or bone marrow stem cells. According to Dr. Sim, in the world today 200 -300 heart failure patients have been transplanted from stem cells, and from 700 to 800 cases of transplantation of bone marrow stem cells.

Particularly in Singapore since 2005, doctors have applied this method to 8 cases of end-stage heart failure. The majority of patients who apply stem cell transplantation are those with myocardial infarction, myocardial ischemia.

Currently, Singapore doctors are studying ways to further refine germ cells in order to achieve better treatment results.

The cost of treating end-stage heart failure with a stem cell transplant method of 20,000 - 30,000 USD

Also at the press conference, Dr. Lim Tai Tian, ​​Parkway Medical Consultant, Parkway Medical Group emphasized that the more risk factors and cardiovascular disease the more exponential. This means that for every person with a risk factor, the likelihood of getting sick is 4 times higher than that of a normal person and a person with two risk factors, which increases 8 times.

Risk factors include, a family history of cardiovascular disease, especially cardiovascular disease from a young age, smokers, hypertension, diabetes, obesity in the abdomen, and men. over 40 years old and women in premenopausal or over 50 years old.

Sand incense